PD-L1 tumor proportion scores range from 0% to >90%, dictating both the probability and durability of cytotoxic T-cell engagement, while baseline tumor mutational burden, HLA diversity, neoantigen clonality, and the density of suppressive myeloid subsets further calibrate intrinsic immunogenicity. Here, CD274 is linked to neoplasm.